CCIA
MYOV

Campbell & Co Investment Adviser’s Myovant Sciences Ltd. MYOV Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,900
Closed -$357K – 879
2021
Q3 		$357K Buy
15,900
+4,500
+39% +$98.8K 0.12% 318
2021
Q2 		$260K Buy
+11,400
New +$240K 0.11% 367

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Campbell & Co Investment Adviser's MYOV Position: Q4 2021 in Review

Campbell & Co Investment Adviser sold out of Myovant Sciences Ltd. (MYOV) in Q4 2021, closing a stake of 15,900 shares — an estimated $357K sold.

Campbell & Co Investment Adviser first reported a position in MYOV in Q2 2021 and held it in 2 quarters. The position peaked at $357K in Q3 2021. 110 funds tracked by Wall St. Rank hold MYOV as of Q4 2021.

  • Campbell & Co Investment Adviser reported no remaining Myovant Sciences Ltd. position as of Q4 2021 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 15,900 Myovant Sciences Ltd. shares in Q4 2021, an estimated $357K.
  • Campbell & Co Investment Adviser first reported a position in Myovant Sciences Ltd. in Q2 2021 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's Myovant Sciences Ltd. position peaked at $357K in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2021.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2021, filed 10 Feb 2022.